JPRN-jRCT2031200242已完成1 期
A Single-Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of LY3537031 in Healthy Participants - J2S-MC-GZMA
Wakayama Naohiko0 个研究点目标入组 60 人开始时间: 2020年12月15日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 65age old（—）
- 性别
- All
入选标准
- •Are male or female not of childbearing potential
- •- Have a body mass index (BMI) between 19 and 35 kg/m2 and a body weight >= 54kg
- •- Have blood pressure, pulse rate, blood and urine laboratory test results that are acceptable for the study
- •- Have veins suitable for blood sampling
排除标准
- •- Have or used to have health problems or laboratory test results or ECG readings that, in the opinion of the doctor, could make it unsafe to participate, or could interfere with understanding the results of the study
- •- Have a diagnosis or history of cancer or malignant disease within 5 years
- •- Have been treated with prescription and over-the-counter medications that promote weight loss within 3 months prior to screening
- •- Show clinical evidence of syphilis, HIV, hepatitis C, or hepatitis B, and/or test positive
- •- Have undergone any form of bariatric surgery
- •- Have previously completed or withdrawn from this study
- •- Are currently participating in or completed a clinical trial within the last 3 months
- •- Regularly use known drugs of abuse or with positive drug results
- •- Smoke >10 cigarettes per day or the equivalent, or are unable or unwilling to refrain from nicotine during CRU admission
研究者
相似试验
招募中
1 期
A Single Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3209590 in Japanese Patients with Type 2 Diabetes MellitusJPRN-jRCT2080223988Eli Lilly Japan K.K.
进行中（未招募）
不适用
Single-Dose, Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Bronchodilatory Effects of Glycopyrrolate Inhalation Solution (GIS) Using a High Efficiency Nebulizer in Patients with COPDChronic Obstructive Pulmonary Disease (COPD)MedDRA version: 9.1Level: LLTClassification code 10010952Term: COPDEUCTR2009-010821-38-GBElevation Pharmaceuticals, Inc12
已完成
不适用
A single ascending dose trial to investigate the safety, tolerability, pharmacokinetics, pharmacodynamics, and food effect of orally administered AS-0871 in healthy subjectsRheumatoid arthritisNL-OMON49497Carna Biosciences, Inc.16
已完成
不适用
A Phase 1 Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IV SYNT001 in Healthy Volunteers.NL-OMON45830Syntimmune32
已完成
不适用
A study in healthy males to assess the safety and tolerability of two different formulations of the study drug, (MSP-2017), administered intranasally.This study is for healthy volunteers. The intended use of the investigational product is to self-terminate acute episodes of paroxysmal supraventricular tachycardia (PSVT), a non-life threatening cardiac arrhythmia.Cardiovascular - Coronary heart diseaseACTRN12613000971730CPR Pharma Services48